These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
472 related items for PubMed ID: 7506680
21. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Aden U, Jung-Hoffmann C, Kuhl H. Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261 [Abstract] [Full Text] [Related]
22. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G. Int J Fertil Menopausal Stud; 1994 Aug; 39(5):283-91. PubMed ID: 7820162 [Abstract] [Full Text] [Related]
23. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function. Prasad RN, Koh S, Ratnam SS. Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360 [Abstract] [Full Text] [Related]
24. Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol. Cullberg G. Acta Obstet Gynecol Scand Suppl; 1985 Apr; 133():1-30. PubMed ID: 3161265 [Abstract] [Full Text] [Related]
25. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT. Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [Abstract] [Full Text] [Related]
26. Effects of three low-dose oral contraceptive formulations on lipid metabolism. Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L. Acta Obstet Gynecol Scand; 1987 Nov; 66(4):327-32. PubMed ID: 2962417 [Abstract] [Full Text] [Related]
27. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors. Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P. Contraception; 1991 Jan; 43(1):23-31. PubMed ID: 1825970 [Abstract] [Full Text] [Related]
28. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. van der Vange N, Blankenstein MA, Kloosterboer HJ, Haspels AA, Thijssen JH. Contraception; 1990 Apr; 41(4):345-52. PubMed ID: 2139843 [Abstract] [Full Text] [Related]
29. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives. Coenen CM, Thomas CM, Borm GF, Rolland R. Int J Fertil Menopausal Stud; 1995 Apr; 40 Suppl 2():92-7. PubMed ID: 8574256 [Abstract] [Full Text] [Related]
30. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol. Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A. Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317 [Abstract] [Full Text] [Related]
31. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen. Sobbrio GA, Granata A, Granese D, D'Arrigo F, Panacea A, Nicita R, Pullè C, Trimarchi F. Clin Exp Obstet Gynecol; 1991 Mar; 18(1):43-5. PubMed ID: 1829029 [Abstract] [Full Text] [Related]
32. Hormonal and nonhormonal factors affecting sex hormone-binding globulin levels in blood. Thijssen JH. Ann N Y Acad Sci; 1988 Mar; 538():280-6. PubMed ID: 3056190 [Abstract] [Full Text] [Related]
33. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne. Palatsi R, Reinilä M, Kivinén S. Acta Derm Venereol; 1986 Mar; 66(3):225-30. PubMed ID: 2426899 [Abstract] [Full Text] [Related]
34. Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months. Dibbelt L, Knuppen R, Jütting G, Heimann S, Klipping CO, Parikka-Olexik H. Contraception; 1991 Jan; 43(1):1-21. PubMed ID: 1825969 [Abstract] [Full Text] [Related]
35. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Petersen KR, Sidelmann J, Skouby SO, Jespersen J. Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344 [Abstract] [Full Text] [Related]
36. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L. Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [Abstract] [Full Text] [Related]
37. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I. Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817 [Abstract] [Full Text] [Related]
38. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A. Int J Fertil Menopausal Stud; 1995 Dec; 40 Suppl 2():98-104. PubMed ID: 8574257 [Abstract] [Full Text] [Related]
39. Hemostasis profile in women taking low-dose oral contraceptives. David JL, Gaspard UJ, Gillain D, Raskinet R, Lepot MR. Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579 [Abstract] [Full Text] [Related]
40. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters. Jung-Hoffmann C, Fitzner M, Kuhl H. Horm Res; 1991 Jul; 36(5-6):238-46. PubMed ID: 1823082 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]